These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31124758)
1. Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges. Barkat MA; Beg S; Pottoo FH; Ahmad FJ Nanomedicine (Lond); 2019 May; 14(10):1323-1341. PubMed ID: 31124758 [TBL] [Abstract][Full Text] [Related]
2. The battle of "nano" paclitaxel. Sofias AM; Dunne M; Storm G; Allen C Adv Drug Deliv Rev; 2017 Dec; 122():20-30. PubMed ID: 28257998 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models. Chen H; Huang S; Wang H; Chen X; Zhang H; Xu Y; Fan W; Pan Y; Wen Q; Lin Z; Wang X; Gu Y; Ding B; Chen J; Wu X Drug Deliv; 2021 Dec; 28(1):1067-1079. PubMed ID: 34109887 [TBL] [Abstract][Full Text] [Related]
5. Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel. Chen S; Song Z; Feng R Anticancer Agents Med Chem; 2020; 20(18):2169-2189. PubMed ID: 32682385 [TBL] [Abstract][Full Text] [Related]
7. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
9. Reinvention of chemotherapy: drug conjugates and nanoparticles. Nguyen-Ngoc T; Raymond E Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982 [TBL] [Abstract][Full Text] [Related]
10. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
12. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. Wang F; Porter M; Konstantopoulos A; Zhang P; Cui H J Control Release; 2017 Dec; 267():100-118. PubMed ID: 28958854 [TBL] [Abstract][Full Text] [Related]
13. Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice. Xie F; De Clercq K; Vervaet C; Van Bocxlaer J; Colin P; Vermeulen A Pharm Res; 2019 Jun; 36(9):127. PubMed ID: 31236836 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma. Pei Q; Hu X; Liu S; Li Y; Xie Z; Jing X J Control Release; 2017 May; 254():23-33. PubMed ID: 28359677 [TBL] [Abstract][Full Text] [Related]
15. Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp. Zhao M; Lei C; Yang Y; Bu X; Ma H; Gong H; Liu J; Fang X; Hu Z; Fang Q PLoS One; 2015; 10(7):e0131429. PubMed ID: 26182353 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
17. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Ruttala HB; Ko YT Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422 [TBL] [Abstract][Full Text] [Related]
19. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model. Ajorlou E; Khosroushahi AY; Yeganeh H Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046 [TBL] [Abstract][Full Text] [Related]
20. Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients. Capasso Palmiero U; Morosi L; Lupi M; Ponzo M; Frapolli R; Zucchetti M; Ubezio P; Morbidelli M; D'Incalci M; Bello E; Moscatelli D Macromol Biosci; 2018 Oct; 18(10):e1800164. PubMed ID: 30047229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]